Abstract
The cell establishes heritable patterns of active and silenced chromatin via interacting factors that set, remove, and read epigenetic marks. To understand how the underlying networks operate, we have dissected transcriptional silencing in pericentric heterochromatin (PCH) of mouse fibroblasts. We assembled a quantitative map for the abundance and interactions of 16 factors related to PCH in living cells and found that stably bound complexes of the histone methyltransferase SUV39H1/2 demarcate the PCH state. From the experimental data, we developed a predictive mathematical model that explains how chromatin-bound SUV39H1/2 complexes act as nucleation sites and propagate a spatially confined PCH domain with elevated histone H3 lysine 9 trimethylation levels via chromatin dynamics. This “nucleation and looping” mechanism is particularly robust toward transient perturbations and stably maintains the PCH state. These features make it an attractive model for establishing functional epigenetic domains throughout the genome based on the localized immobilization of chromatin-modifying enzymes.
Keywords: FRAP/FCS, heterochromatin protein 1, histone methylation, pericentric heterochromatin, protein network
Introduction
Epigenetic networks control the accessibility of DNA for transcription, DNA repair, and replication machineries. They establish and maintain different functional chromatin states through cell division via protein factors that set or remove specific modifications of histones and DNA in the absence of alterations of the DNA sequence (Berger et al, 2009). These chromatin signals in turn recruit architectural chromatin components or chromatin remodeling factors in a highly dynamic manner and regulate genome access (McBryant et al, 2006; Taverna et al, 2007; Campos & Reinberg, 2009; Clapier & Cairns, 2009; Erdel et al, 2011a). On a global scale, the concerted and targeted activity of these networks results in the formation of the denser, transcriptionally repressed heterochromatin state and the more open and biologically active euchromatin, which can be distinguished at the resolution of the light microscope (Grewal & Jia, 2007; Eissenberg & Reuter, 2009). A prototypic example for a constitutive heterochromatin domain is pericentric heterochromatin (PCH) in mouse cells (Probst & Almouzni, 2008). It is characterized by its high content of repetitive major satellite repeats and repressive epigenetic marks such as 5-methylcytosine (5meC) the binding of proteins with a methyl-CpG-binding domain that recognize this modification, trimethylation of histone H3 lysine residue 9 (H3K9me3), and histone H4 lysine residue 20 (H4K20me3), as well as hypoacetylation of histones (Probst & Almouzni, 2008). The H3K9me3 modification is set by the histone methylases SUV39H1 and SUV39H2 (in the following “SUV39H” refers to both isoforms), while SUV4-20H1 and SUV4-20H2 set H4K20me2 and promote H4K20me3 (“SUV4-20H” for both isoforms) (Kwon & Workman, 2008; Schotta et al, 2008; Eissenberg & Reuter, 2009; Byrum et al, 2013).
A central protein component of PCH is heterochromatin protein 1 (HP1) that is present in three very similar isoforms HP1α, HP1β, and HP1γ in mice and humans (Maison & Almouzni, 2004; Hiragami & Festenstein, 2005; Kwon & Workman, 2008). HP1 contains an N-terminal chromodomain (CD) and a C-terminal chromoshadow-domain (CSD) connected by a flexible linker region. The CD interacts specifically with H3 histone tails that carry the K9me3 modification (Jacobs & Khorasanizadeh, 2002; Fischle et al, 2003). HP1 is able to form homo- and heterodimers (Nielsen et al, 2001; Yamamoto & Sonoda, 2003; Rosnoblet et al, 2011), interacts with SUV39H1 (Aagaard et al, 1999; Yamamoto & Sonoda, 2003), SUV4-20H2 (Schotta et al, 2004; Souza et al, 2009), the DNA methylase DNMT1 (Fuks et al, 2003; Lehnertz et al, 2003; Smallwood et al, 2007) as well as the methyl-CpG-binding proteins MBD1 and MECP2 (Fujita et al, 2003; Agarwal et al, 2007). SUV39H1 interacts with the DNA methylation-associated proteins DNMT1, MBD1, and MECP2 (Lunyak et al, 2002; Fujita et al, 2003; Fuks et al, 2003; Esteve et al, 2006). Thus, a complex protein–protein interaction network exists in PCH. The interactions constituting this network in mammalian cells have been studied mostly in vitro or via immunoprecipitation experiments and have not been probed comprehensively in living cells.
Since HP1 interacts with SUV39H via its CSD, a feedback loop of HP1 binding-mediated H3K9 methylation has been proposed as a mechanism for propagating the H3K9me3 mark to adjacent nucleosomes (Schotta et al, 2002; Grewal & Jia, 2007; Eissenberg & Reuter, 2009). Theoretical models based on a combination of such feedback loops have suggested the existence of two discrete chromatin states that can stably co-exist (“bistability”) for a certain range of conditions (Schreiber & Bernstein, 2002; Dodd et al, 2007; Angel et al, 2011). Hathaway et al have proposed an alternative, “monostable” model of heterochromatin propagation through interactions between neighboring nucleosomes (Hathaway et al, 2012). However, direct evidence on how such epigenetic networks might operate in living cells is lacking. In particular, three crucial questions remained unanswered: (i) How is the separation of the genome in active and silenced chromatin states established and maintained and what are the factors that provide specificity for distinct euchromatic and heterochromatic states? (ii) How is the confinement of a given chromatin state to a certain genomic locus achieved? For the case of a feedback loop between SUV39H, HP1, and H3K9me3 in PCH, it is elusive why the H3K9me3 does not spread throughout the whole genome. (iii) How is a given chromatin state like that of PCH transmitted through the cell cycle?
Here, we have set out to address these issues by dissecting the mouse pericentric heterochromatin network centered around the H3K9 and H4K20 methylation. This model system has the advantage that the corresponding heterochromatin domains can be readily identified on fluorescence microscopy images as chromatin-dense spots, the chromocenters. Accordingly, we were able to distinguish the features of PCH from the surrounding bona fide euchromatin. By applying a combination of fluorescence microscopy-based imaging, bleaching and correlation methods (Müller et al, 2009; Erdel et al, 2011b) in conjunction with quantitative mechanistic modeling, we identified distinct complexes of stably bound SUV39H as the component that defines the PCH state. We further demonstrate that these SUV39H complexes represent “nucleation sites” that are sufficient to provide specificity, confined propagation of the H3K9me3 mark as well as cellular memory to transmit the PCH state through the cell cycle.
Results
The repressive PCH state is defined by enrichment of 5meC, MECP2, MBD1, and SUV39H
We quantitated the enrichment of the PCH-associated histone modifications H3K9me3, H4K20me3, the DNA methylation 5meC and the known proteins that set, remove, or recognize these modifications in the context of PCH in mouse NIH-3T3 fibroblasts: the histone H3K9 and histone H4K20 specific methylases SUV39H1, SUV39H2, SUV4-20H1, SUV4-20H2, all three isoforms of the H3K9me3-reader HP1 (HP1α, HP1β, and HP1γ), the histone demethylases JMJD2B and JMJD2C that remove H3K9me3, the DNA methylase DNMT1 as well as the methyl-CpG binding domain (MBD)-containing proteins MECP2, MBD1, MBD2, and MBD3 [see (Fodor et al, 2010) for a review of previously identified mammalian PCH components]. Furthermore, we included the transcription factors PAX3, PAX5, PAX7, and PAX9 in our analysis since a role for PAX3 in PCH assembly has been reported (Bulut-Karslioglu et al, 2012). Although the colocalization of these factors and histone marks with PCH was studied previously, a comprehensive quantitative analysis of their PCH-specificity and abundance has been lacking. Thus, we fluorescently labeled the factors of interest (Supplementary Fig S1) and determined the enrichment of GFP-tagged proteins in PCH using the workflow shown in Fig 1A: For each factor, the fluorescence intensity was measured in PCH as defined by foci with intense DAPI (4′,6-diamidino-2-phenylindole) staining and in the surrounding euchromatin of G1 phase cells. The enrichment of these factors in PCH was calculated, followed by normalization to the enrichment of core histone H2A and DAPI in PCH. Chromatin binding states were identified by fluorescence recovery after photobleaching (FRAP) and their enrichment in PCH was determined. Fluorescence correlation spectroscopy (FCS) was used to measure protein concentrations and the free diffusion coefficient in the cytoplasm, which served as a reference value. Protein enrichments, concentrations, chromatin binding states, and protein–protein interactions were integrated into a quantitative molecular model for PCH.
PCH was about 1.8 ± 0.3-fold denser than euchromatin as determined from the H2A-RFP intensity, whereas the DNA stain with DAPI yielded a 2.7 ± 0.1-fold enrichment in PCH, possibly reflecting its binding preference for A/T-rich sequences. We conclude that chromatin is about 2-fold more compacted in PCH (Fig 1B). In terms of factors targeted to PCH during G1, we identified three different groups (Fig 1B): (i) Proteins displaying a diffuse distribution throughout the nucleus or a slight depletion in PCH, which is indicative of little PCH-specific interactions (JMJD2B/C, DNMT1, MBD3, and the PAX proteins). (ii) Factors whose PCH enrichment (2–3-fold) essentially followed the increased chromatin density and accordingly displayed only moderate specificity for PCH (MBD2, HP1, and H3K9me3). When normalized to the H2A-RFP chromatin density, the average enrichment of H3K9me3 in PCH was only 1.4 ± 0.2-fold. Measured values ranged from 0.8- to 1.6-fold between different experiments and antibodies used (Millipore and Abcam). (iii) Factors that were clearly enriched above the 2-fold DNA compaction in PCH and thus represent PCH-specific components (5meC, MECP2, MBD1, SUV39H, H4K20me3, SUV4-20H: ∼4- to 10-fold). The PCH enrichment of 5meC measured by immunostaining varied between 2- and 5-fold, depending on antibody and fixation protocols used. From bisulfite sequencing data of major satellite repeats in NIH-3T3 cells, mouse embryonic stem cells (ESCs), and primary differentiated cells, we calculated an enrichment of 7 ± 1 (Wilson & Jones, 1984; Yamagata et al, 2007; Meissner et al, 2008; Arand et al, 2012).
To validate the functional role of SUV39H and H3K9me3 in PCH of our cellular system, we measured the abundance of satellite transcripts by quantitative real-time PCR in ESCs, immortalized mouse embryonic fibroblasts (iMEFs) and iMEFs that had Suv39h1 and Suv39h2 (iMEF Suv39h dn) deleted (Peters et al, 2001). The transcription levels of pericentric major satellites were 4.6 ± 0.2-fold higher in ESCs and 14 ± 2-fold higher in iMEF Suv39h dn cells as compared to fully differentiated iMEF wild-type (wt) cells (Supplementary Fig S2A). Thus, PCH-specific H3K9me3 levels in wild-type iMEFs, ESCs, and Suv39h dn iMEFs anti-correlate with satellite repeat transcription, in agreement with previous measurements (Lehnertz et al, 2003; Martens et al, 2005; Meshorer & Misteli, 2006). Importantly, the chromatin-dense chromocenters persisted in both Suv39h and Suv4-20h double null cells, showing that transcriptional silencing is not due to chromatin compaction per se (Supplementary Fig S2B and C). Decondensation of the chromocenters was only observed upon inhibition of histone deacetylation (Supplementary Fig S2D) in agreement with previous reports (Taddei et al, 2001). In summary, we conclude that the enrichment of 5meC as well as MECP2, MBD1, SUV39H1, and SUV39H2 proteins represent the hallmarks of PCH.
MECP2, SUV39H, and HP1 are the most abundant stably PCH-associated proteins
The above quantitative analysis of relative steady-state PCH enrichment levels lacks information on the absolute endogenous protein concentrations and does not resolve differences in binding kinetics. To address these issues, we integrated FCS and FRAP (Supplementary Fig S3A) (Müller et al, 2009). By combining quantitative FCS and Western blot analysis, endogenous SUV39H and SUV4-20H concentrations were determined to be between 0.1–0.4 μM in euchromatin and 0.2–3.0 μM in PCH (Supplementary Fig S3B and C, Table 1, Supplementary Table S1). HP1 displayed the highest concentration of the factors studied of 19 ± 12 μM in euchromatin and 41 ± 25 μM in PCH, with HP1β and HP1γ being significantly more abundant than HP1α (Table 1, Supplementary Table S1). The diffusion coefficients measured by FCS in the cytoplasm were in the expected range and represent a reference value for the intracellular protein mobility of a given factor in the absence of chromatin interactions (Supplementary Table S1).
Table 1.
Endogenous protein concentrations are given in terms of monomers. Values were determined from FCS measurements of GFP-tagged proteins (Supplementary Table S1) and APD-imaging (Supplementary Materials and Methods). The ratio of endogenous to exogenous protein concentrations in the cytoplasm (Cyto), euchromatin (Eu), and heterochromatin (PCH) was determined by quantitative Western blot analysis. The minimal number of binding classes was determined from FRAP measurements and subsequent data fitting to either a diffusion or a reaction-diffusion model. From the fit, fractions of each binding class were determined and residence times were calculated according to τres = 1/koff.
a Values for endogenous SUV39H2 and MECP2 concentrations were determined from RNA expression levels measured in iMEF cells relative to SUV39H1 levels.
b For SUV4-20H, concentrations were measured in embryonic stem cells and represent also values in fibroblasts since concentrations do not change significantly during differentiation (Efroni et al, 2008).
c Class III binding of MECP2 in euchromatin was estimated by refitting the FRAP curves with a reaction-diffusion model.
d Class II binding of HP1 was estimated by refitting the FRAP curves with a reaction-diffusion model including a fixed off-rate, which has been determined for heterochromatin.
e For unspecific binding of class I, the residence time τres ≤ 0.5 s is given as an estimate of the upper boundary resulting from the time resolution of the FRAP measurements (not extractable from data fitting).
f The immobile fraction (class IV) is measured from the plateau value of the FRAP curve after measurements for 4–5 min. It gives the lower boundary of the proteins’ residence time for which an approximate value of 4 min was used in the network model.
Chromatin binding in the nucleus was evaluated by FRAP (Fig 1E–H) with a reaction-diffusion analysis that yielded the effective diffusion coefficient Deff (including transient binding interactions), the dissociation rate constant koff, the pseudo on-rate k*on (including the free binding site concentration), and the protein fraction immobilized on the minute time scale (Supplementary Fig S3A). From these data, we calculated average protein residence times τres to different types of binding sites according to the following rationale (Table 1, Supplementary Tables S1 and S2): (i) The difference between Dfree and Deff indicated the presence of a protein pool, which binds transiently with τres ≤ 0.5 s. These represent the lowest affinity binding sites (class I) in our analysis. (ii) Kinetic on- and off-rates determined from the reaction-diffusion fit were used to characterize two additional types of binding sites, class II and class III, with 1/koff = τres in the range of 3–5 s (class II) and 25–100 s (class III). (iii) The highest affinity class IV binding sites comprised the protein fraction that was immobile during the measurement corresponding to a lower limit of τres of approximately 4 min.
Accordingly, we interpret transient interactions (class I) as unspecific chromatin binding interactions. These were present both in PCH and euchromatin and comprised essentially the entire protein pool of the H3K9me3 demethylases JMJD2B/C and the transcription factor PAX3 (Supplementary Table S2, Supplementary Fig S4A and B). Class II and class III binding sites were present in both euchromatin and PCH for the other proteins, albeit at different concentrations. With respect to the immobile protein fractions (class IV), we measured a particularly strong enrichment for MECP2 (∼80-fold), SUV39H1 (∼50-fold), and SUV39H2 (16-fold) in PCH as compared to euchromatin (Fig 1C). Immobile fractions of MBD1, SUV4-20H, and HP1 were about 8-fold enriched in PCH. When calculating the immobile fractions in terms of the absolute protein concentrations, the immobile fraction of the combined HP1 species was the largest (2.7 μM), followed by that of MECP2 (1.6 μM), SUV39H (1.1 μM), SUV4-20H (0.2 μM), and MBD1 (0.2 μM) (Fig 1D). Thus, the amount of immobilized HP1 provides enough protein molecules for interactions with MECP2/MBD1, SUV39H, and SUV4-20H at the high-affinity binding sites, although this HP1 fraction represents only approximately 7% of the total HP1 pool. Accordingly, we conclude that 1–3 μM of MECP2, SUV39H, HP1, and SUV4-20H are tightly bound (koff < 0.005 s−1) at PCH-specific sites that are mostly absent in euchromatin.
PCH proteins form a complex interaction network
Our finding that MECP2/MBD1, HP1, and SUV39H are present at similar concentrations of about 1–3 μM in a stably PCH-attached state (Fig 1D; Table 1) suggests that they assemble into a complex. Accordingly, we mapped their protein interactions in vitro and in living cells (Fig 2, Supplementary Fig S5, Supplementary Tables S3 and S4): First, we used analytical ultracentrifugation (AUC) to measure the association state of full-length HP1β and its isolated CD and CSD at physiological ionic strength. Full-length HP1β formed a dimer with an equilibrium dissociation constant of 1–2 μM (Fig 2A, Supplementary Table S3). No larger complexes were detectable up to a concentration of 30 μM. Dimerization was mediated by the CSD of HP1 since the isolated domain was found to be dimeric while the CD was monomeric in agreement with previous results (Ball et al, 1997; Nielsen et al, 2001). Second, HP1 association in living cells was studied by fluorescence cross correlation spectroscopy (FCCS) after transfecting cells stably expressing GFP-HP1α with RFP-HP1α, β or γ. A soluble nuclear HP1 fraction of 65 ± 34% formed a dimer with either the same HP1 isoform (homodimer) or another isoform (heterodimer) (Fig 2B, Supplementary Fig S5A). Self-association of SUV39H1 was shown with a corresponding approach, yielding an approximately 24% fraction of soluble SUV39H1 present in homodimeric complexes (Supplementary Fig S5A). Third, we applied the fluorescent two-hybrid (F2H) method (Zolghadr et al, 2008; Chung et al, 2011) to evaluate the SUV39H1-SUV39H1 self-association and interactions of HP1-dimers with stably chromatin-bound SUV39H in living cells. Tethering of SUV39H1-GFP to the lacO arrays resulted in the recruitment of RFP-HP1 and SUV39H1-RFP (Fig 2C, Supplementary Fig S5B). Furthermore, a strong interaction of HP1 with MECP2 and MBD1 was observed. However, we could not confirm association of SUV39H1 with the MBD-proteins that was reported elsewhere (Supplementary Fig S5B) (Lunyak et al, 2002; Fujita et al, 2003; Fuks et al, 2003; Esteve et al, 2006). A summary of all (direct or indirect) protein–protein associations for the factors studied here is given in Supplementary Table S4. It reveals that the proteins involved in DNA and histone methylation form a complex interaction network in living fibroblasts. We conclude that several of the above described protein–protein interactions cooperate to target SUV39H to PCH and provide the interaction energy for its stable tethering.
SUV4-20H operates downstream of SUV39H and stabilizes HP1 binding to PCH
SUV39H is required for the enrichment of H3K9me3, H4K20me3, SUV4-20H, and HP1 in PCH, and the loss of H3K9me3 and SUV39H leads to a strong increase in mobility of HP1 in PCH (Supplementary Figs S2B and S4C, Supplementary Table S5) as reported previously (Peters et al, 2001; Schotta et al, 2004; Müller et al, 2009). Immunostaining of 5meC revealed that this mark was maintained in iMEF Suv39h dn cells, and also the MBD-proteins MECP2 [as shown previously in (Brero et al, 2005)] and MBD1 remained enriched in PCH (Supplementary Fig S2B). This confirms that DNA methylation and enrichment of its reader proteins do not rely on SUV39H (Lehnertz et al, 2003; Brero et al, 2005).
To assess the influence of H4K20me3 on PCH, we analyzed heterochromatin proteins and histone modifications in iMEF Suv4-20h dn cells that lack both H4K20-specific methylases SUV4-20H1 and SUV4-20H2 (Supplementary Fig S2C) (Schotta et al, 2008). As expected, the H3K9me3 mark was unperturbed, and SUV39H as well as HP1 were still enriched at the chromocenters (Supplementary Fig S2C, Supplementary Table S5) (Schotta et al, 2004). However, FRAP analyses revealed that HP1 was more mobile in Suv4-20h dn cells as compared to wild-type cells (Supplementary Table S2). In particular, the immobile HP1 fraction was decreased to about half the wild-type value (Supplementary Fig S4D), the residence time of the bound fraction was shorter, and the effective diffusion coefficient increased. This suggests that SUV4-20H can enhance chromatin binding of HP1 although its binding to PCH occurs downstream of H3K9me3, SUV39H, and HP1.
HP1 stabilizes SUV39H1 binding at PCH and promotes H3K9 trimethylation
We knocked down all three HP1 isoforms with siRNAs to evaluate the effect of HP1 on SUV39H binding and H3K9me3 levels in chromocenters versus euchromatin on the single-cell level. The knock-down resulted in a wide range of HP1 expression levels in individual cells (determined by immunostaining) that correlated with SUV39H1 and H3K9me3 intensity signals (Fig 3A). Global nuclear expression levels of stably integrated SUV39H1-GFP followed that of HP1, suggesting that HP1 stabilizes the Suv39h1 transcript or protein. In addition, the PCH enrichment of SUV39H1 was reduced at lower HP1 concentrations. While SUV39H1 expression levels and PCH enrichment were sensitive to HP1 abundance over the complete range of knockdown concentrations, the H3K9me3 levels remained constant for HP1 levels above 80% of the wild-type concentration. Thus, cells were able to compensate for variations of HP1 and SUV39H1 concentrations to some extent. Below 80% of HP1, the heterochromatic H3K9me3 levels decayed gradually with decreasing HP1 expression until euchromatic levels were reached (Fig 3A and B). Thus, HP1 contributes to the enrichment of SUV39H1 in PCH and is required for maintaining wild-type H3K9me3 levels. Euchromatic H3K9me3 levels decreased slightly with reduced HP1 concentrations (Fig 3A). This could be related to interactions of HP1 with the histone methylases G9A and SETDB1 that are preferentially active in euchromatin (Tachibana et al, 2002; Chin et al, 2007; Loyola et al, 2009).
SUV39H is responsible for depositing H3K9me3 preferentially in PCH
To quantify the contribution of SUV39H in catalyzing H3K9 trimethylation, we determined the H3K9me3 levels of euchromatin and PCH in wild-type and Suv39h dn iMEFs based on the relative H3K9me3 immunofluorescence signal in the same sample preparation (Fig 3C, Supplementary Fig S2B). In wild-type cells, an average H3K9me3 level of 38 ± 3% in PCH and 28 ± 1% in euchromatin was calculated based on a total H3K9me3 level of 28% reported previously for mouse fibroblasts (Fodor et al, 2006). The corresponding values in the Suv39h dn cells were 13 ± 2% (PCH) and 25 ± 4% (euchromatin), from which the relative methylation rate of SUV39H can be estimated according to a simple quantitative model: Nucleosomes can carry H3K9me3 (M) or lack this modification (U) (Fig 3D, Supplementary Materials and Methods). Since the JMJD2B/C demethylases were homogeneously distributed in the nucleus and displayed similar mobility in both euchromatin and PCH (Supplementary Fig S4A), the demethylation rate k-m is assumed to be equal in both chromatin states. The resulting H3K9me3 level in each state is solely determined by the ratio of methylation rate km to k-m. This yields an 8-fold preference of SUV39H for methylation of PCH versus euchromatin, while the euchromatin-specific methylation provided by other methylases like SETDB1 and G9A is roughly 2-fold higher in euchromatin than in PCH (Fig 3D). Notably, the SUV39H specificity for PCH correlates well with the enrichment of chromatin-bound SUV39H molecules in PCH (16- to 50-fold, Fig 1C). Thus, we conclude that the SUV39H-dependent H3K9me3 modification is directly related to the amount of chromatin-bound enzyme.
Silenced major satellite repeats are enriched with SUV39H, H3K9me3, HP1, and 5meC
To corroborate that SUV39H binding to chromatin concurs with HP1 and H3K9me3 at sites of DNA methylation, we conducted an analysis by ChIP-seq (chromatin immunoprecipitation followed by DNA sequencing). The enrichment of HP1β, SUV39H1, SUV39H2, and H3K9me3 at major satellite repeats was evaluated in neural progenitor cells (NPCs) using the H3K36me3 modification as a reference signature for transcriptionally active chromatin. NPCs were generated in vitro from ESCs and represent a well-established model system for studying epigenetic modifications and chromatin composition established during differentiation (Teif et al, 2012; Lorthongpanich et al, 2013). SUV39H1, SUV39H2, H3K9me3, and HP1β were enriched at the canonical major satellite repeat sequence while no enrichment was detected for H3K36me3 (Fig 4A and B). Furthermore, we analyzed the distribution of bound proteins at 16 uniquely mappable intergenic/intronic major satellite repeats annotated by the RepeatMasker tool (Fig 4C and D). Of these repeats, 12 were enriched for SUV39H, H3K9me3, and HP1β while H3K36me3 was depleted. Another two repeats resided in an inactive state with low H3K36me3 and higher H3K9me3 levels but lacked enrichment of SUV39H or HP1β. In contrast, the two active repeats carrying H3K36me3 lacked SUV39H, H3K9me3, and HP1β. Thus, the ChIP-seq analysis corroborates our conclusions that stable chromatin binding of SUV39H and transcriptional repression of major repeats correlate with the presence of HP1 and H3K9me3. Based on the 5meC distribution reported elsewhere (Lorthongpanich et al, 2013), we calculated CpG methylation levels of 88 ± 8% at the 12 inactive intergenic/intronic repeats loaded with SUV39H, H3K9me3, and HP1. The two active repeats had similar CpG densities and similar CpG methylation levels of 86 ± 2%. Since the normalized 5meC density was only slightly higher at 1.3 ± 0.1-fold for silenced repeats compared to transcribed ones, we conclude that 5meC is not the dominant silencing factor for these repeats.
SUV39H methylases remain attached to chromatin during mitosis
Many proteins remain attached to PCH during mitosis (Lewis et al, 1992; Fujita et al, 1999; Bachman et al, 2001; Craig et al, 2003; Hayakawa et al, 2003; Easwaran et al, 2004; Kourmouli et al, 2004; Mateescu et al, 2004; Brero et al, 2005; Fischle et al, 2005; Hirota et al, 2005; McManus et al, 2006; Schermelleh et al, 2007; Hahn et al, 2013). Thus, the PCH state might be transmitted through cell division by stably bound bookmarking factors. Since SUV39H1 also remains bound to chromosomes in metaphase (Melcher et al, 2000), we analyzed its localization in all mitotic phases (Fig 5A). Notably, SUV39H1 remained attached to chromatin through mitosis. From FRAP experiments on mitotic cells, we found 5 ± 3% of SUV39H1 stably bound to chromatin (Fig 5B, Supplementary Table S6). Since euchromatin and PCH cannot be distinguished on mitotic chromosomes, this should be compared to the weighted average of bound SUV39H1 in PCH and euchromatin of interphase cells (4 ± 1%). Thus, most SUV39H remained stably bound, suggesting that it serves a bookmarking function for PCH.
The cell cycle-dependent chromatin interactions of HP1 and SUV39H1 were further analyzed by FRAP (Supplementary Table S6). Co-transfection of RFP-tagged proliferating cell nuclear antigen (PCNA) served as a marker for G1 and S phase and delocalized HP1 as an indicator for G2 phase. SUV39H1 showed relatively similar chromatin interaction throughout interphase (Supplementary Fig S1C, Supplementary Table S6). All HP1 isoforms had comparable cell cycle-dependent mobility, and HP1α is shown as an example (Supplementary Table S6). While HP1 exhibited considerable chromatin binding in G1 and S phase consistent with previous findings (Cheutin et al, 2003; Festenstein et al, 2003; Schmiedeberg et al, 2004; Dialynas et al, 2007), HP1 mobility could best be described by a diffusion model for both euchromatin and PCH in G2, indicating significantly reduced chromatin interactions. The immobile fraction in PCH was reduced to euchromatin values of 3 ± 2%. The remaining fraction of approximately 3% stably tethered HP1 corresponds to a concentration of 1.2 μM, which is similar to the amount of immobile SUV39H and SUV4-20H in PCH. In summary, our combined imaging- and FRAP-based analyses provide evidence that a considerable fraction of SUV39H remains stably bound to chromatin throughout the cell cycle including all phases of mitosis. Likewise, H3K9me3, HP1, 5meC, MECP2, and MBD1 remained available to enhance SUV39H chromatin interactions. This is consistent with an inheritance mechanism in which the PCH state is transmitted via chromatin-bound bookmarking factors.
Stable SUV39H-containing complexes in PCH arise from multiple protein–protein interactions
Our protein–chromatin and protein–protein interaction data can be rationalized with a model in which SUV39H and HP1 can bind either separately to weaker affinity binding sites with ΔGSUV39H and ΔGHP1, respectively, or to high-affinity sites where both proteins interact with chromatin and are additionally linked by protein–protein interactions. This interaction could be further stabilized by MECP2 or MBD1, which themselves display high-affinity PCH binding, or by other additional factors. The binding free energy ΔGHP1-SUV39H of an HP1-SUV39H complex to these high-affinity sites can be approximated as ΔGHP1 + ΔGSUV39H. Based on our FRAP data (Supplementary Table S2), dissociation constants and residence times for the individual binding reactions to H3K9 trimethylated nucleosomes are Kd = 19 μM and τres = 3 s for HP1, and Kd = 4 μM and τres = 13 s for SUV39H1. Together, these contributions lead to a highly stable chromatin-bound HP1-SUV39H complex with Kd ≈ 0.07 nM and a corresponding residence time of several minutes, which is consistent with the immobile fraction in our FRAP experiments. Based on the limiting concentration measured for immobilized SUV39H (Table 1, Supplementary Table S7), this complex can only be sparsely distributed throughout PCH, that is the stoichiometry equals one complex per 170 nucleosomes.
Immobilized SUV39H1 is sufficient to form a de novo H3K9me3 domain
The correlation between the highly enriched stably chromatin-bound SUV39H fraction (Fig 1C) and the steady-state H3K9me3 levels (Fig 3C) in PCH prompted us to ask whether these stably bound complexes are responsible for the deposition of H3K9me3 in PCH. To test if immobilized SUV39H1 is sufficient to establish a methylated chromatin domain, GFP-SUV39H1 was tethered to the nuclear lamina via a GFP-binding protein that was fused to Lamin B1 (Rothbauer et al, 2008) in living iMEF Suv39h dn cells. Subsequently, the localization of H3K9me3 was monitored with an RFP-tagged chromodomain (CD) of HP1 (Fig 6A and B). A quantitative analysis of the averaged H3K9me3 profile across the lamina revealed de novo H3K9me3 modifications at the nuclear lamina for wild-type SUV39H1 but not for the inactive SUV39H1-H324L-mutant (Fig 6A and C). Thus, immobilized SUV39H methylates nucleosomes that are brought into spatial proximity. The slightly increased width of the profile at half maximum for H3K9me3 (0.47 ± 0.03 μm) versus that of GFP-SUV39H1 (0.40 ± 0.02 μm) indicated that the newly formed H3K9me3 regions extended for < 0.1 μm into the nuclear interior. Thus, the trimethylation mark did not spread beyond those chromatin loci that could transiently interact with tethered SUV39H1 via chromatin dynamics, although free GFP-SUV39H1 was present in the nucleoplasm as detected by FCS.
We conclude that the endogenous propagation of H3K9me3 in PCH can originate from relatively sparsely distributed immobilized SUV39H complexes that locally extend H3K9me3 to spatially adjacent sites. The underlying molecular spreading mechanism might be chromatin looping that can efficiently promote interactions within limited genomic distances of several kilobases or < 100 nm (Rippe, 2001; Erdel et al, 2013).
The dynamics of protein binding and histone modifications in PCH can be integrated into a quantitative network model
Based on our experimental observations and data analysis, we developed a quantitative model for the epigenetic network centered around H3K9me3 in PCH with all parameters compiled in Supplementary Table S7. It is based on stably bound SUV39H complexes that are specifically tethered to PCH via multiple interactions (Fig 4E). These SUV39H complexes represent nucleation sites that mediate confined propagation of H3K9me3 via chromatin looping (Rippe, 2001; Erdel et al, 2013) (Fig 7A). In particular, such a mechanism rationalizes the experimental findings on the limited extension of H3K9me3 from SUV39H1 bound to the nuclear lamina (Fig 6) as well as the size of histone methylation domains that have been found around chromatin-tethered proteins (Erdel et al, 2013).
Our quantitative model focuses on the signature heterochromatin mark H3K9me3 and its interacting proteins, HP1 and SUV39H, in an extended chromatin segment (300 nucleosomes or ∼60 kb DNA). Each nucleosome can either reside in the unmodified state “n” or in the H3K9 trimethylated state “m” (Fig 7B). Depending on the presence of HP1 (“H”) and SUV39H (“S”), the chromatin-bound complexes “Hm”, “Sm”, and “SHm” can assemble. The PCH-specific high-affinity binding sites for SUV39H and HP1 are referred to as origins “o”, which can either be free, occupied by SUV39H (“So”) or HP1 (“Ho”) alone, or by the HP1-SUV39H complex (“SHo”). According to our experimental data, every 8th nucleosome in PCH and every 71st nucleosome in euchromatin is an origin (see Supplementary Materials and Methods, Mathematical modeling of PCH network). Based on the experimentally measured immobile SUV39H fractions and concentrations, every 21st origin, that is every 170th nucleosome, is in the SHo state at a given point of time. All parameters used in the modeling and their sources are given in Supplementary Table S7.
The model quantitatively accounts for the different experimentally observed types of binding sites for SUV39H1 and HP1 and their occupancy. For the H3K9 trimethylation reaction, we distinguish different pathways. Freely mobile SUV39H at a concentration cs methylates nucleosomes with a basal rate km·cs. H3K9 trimethylation by other histone methylases like G9A/SETDB1 is accounted for as an additional reaction with rate constant ku in PCH and ke+ku in euchromatin. Finally, chromatin-bound SUV39H catalyzes H3K9 trimethylation via chromatin looping. The efficiency for trimethylating H3K9 in a nucleosome at distance b from the SUV39H-bound site corresponds to km·jM(b). Here, jM(b) is the local concentration of the respective complex in proximity of the target nucleosome (Erdel et al, 2013) (Fig 7A). Importantly, we do not assume that chromatin-bound SUV39H is intrinsically more active than free SUV39H but that the decisive factor is the enhanced local concentration of the former.
For our model, the association and dissociation rates and the concentrations of free proteins were taken as determined from the FRAP and FCS experiments (Supplementary Materials and Methods, Supplementary Table S7). To simplify the model, we combined the parameters for SUV39H1 and SUV39H2 weighted according to their concentrations into a unified SUV39H enzyme (Supplementary Table S7). The rate constant for H3K9me3 demethylation was fixed to k-m = 0.0013 min−1 according to mass spectrometry experiments in HeLa cells (Zee et al, 2010). The unspecific methylation rate ku, the euchromatin-specific rate ke, and the SUV39H-dependent methylation rate km were fitted to yield the measured steady-state levels of H3K9me3 in PCH (38%) and euchromatin (28%) of wild-type cells (Fig 3C). The system was formulated as a set of deterministic ordinary differential equations (ODEs) to calculate the steady-state probabilities of each nucleosome to be in a particular state for a given set of conditions and, in parallel, simulated stochastically (Fig 7C and D; Supplementary Model Code). The model simulations show that the relatively sparse binding events of SUV39H at the origin sites are sufficient to account for the increased H3K9me3 levels in PCH compared to euchromatin (Fig 7C and D). At any given nucleosome, the methylation state fluctuates over time (Fig 7D). However, the time average is consistently described by the stochastic and deterministic models and yields the observed enrichment of H3K9me3 in PCH over euchromatin as well as the measured occupancies of HP1 and SUV39H. Thus, we conclude that PCH-specific high-affinity SUV39H/HP1 binding sites can robustly maintain the PCH-specific H3K9me3 levels via a DNA looping mechanism.
Stochastic simulations reveal that PCH-specific features are robustly maintained for the experimentally determined parameter range
Several experimental and theoretical studies showed that the epigenetic silencing mechanisms can be sensitive to stochastic effects either due to the presence of positive feedback loops in nucleosome modification (Sneppen et al, 2008), long-range nucleosomal interactions (Dodd et al, 2007), the cooperativity in recruitment of histone modifiers (Sedighi & Sengupta, 2007) or simply due to low protein concentrations. Accordingly, we evaluated our model with respect to the degree of intrinsic noise that can cause stochastic focusing effects by conducting Monte Carlo simulations according to the Gillespie stochastic simulation algorithm. An example for the resulting fluctuations of the states in which individual nucleosomes are present in PCH or in euchromatin is depicted in Fig 7D. Relatively sparse binding events of SUV39H at the “o” sites are sufficient to increase H3K9me3 levels compared to euchromatin. For both the PCH and euchromatin state, we simulated 100 individual time traces up to 5,000 min starting from an initially naive non-modified fiber (Fig 7D). The low variability of H3K9me3 in steady state revealed that the level of intrinsic noise in our model is very low when averaged over the entire nucleosome chain, with a standard deviation of approximately 3% from the population-mean for PCH. As expected, the spatial steady-state distribution of H3K9me3 modifications over the entire chain agreed well with the deterministic solutions for all conditions (Fig 7C). Thus, we conclude that the system robustly maintains the PCH-specific H3K9me3 levels.
The cellular response to perturbations of the H3K9me3 state is accurately predicted by the network model
We systematically investigated the predictions of our model with respect to the response of the system to perturbations induced by (i) lowering the HP1 concentration, (ii) increasing the H3K9me3 demethylation activity or (iii) changing the concentration of origin sites. First, we evaluated the distribution of H3K9me3 levels in model simulations for different HP1 concentrations. SUV39H binding and H3K9me3 levels gradually decreased when lowering the HP1 concentrations, consistent with the behavior observed in the HP1 knockdown experiments (Fig 8A and B). Second, we mimicked the increase of H3K9me3 demethylation activity by raising the corresponding parameter k-m. This resulted in a gradual decrease of H3K9me3 in PCH, which contradicts the notion of bistable states. To test this behavior of the system experimentally, we overexpressed JMJD2C, an H3K9me3-specific histone demethylase, to reduce H3K9 trimethylation (Fig 8C). H3K9me3 levels were evaluated in PCH of single cells on fluorescence microscopy images, normalized to the DAPI signal, and correlated with the JMJD2C-GFP expression levels. The relation of demethylation rate and H3K9me3 levels predicted from our model was in good agreement with the experimental data and showed a gradual decrease of H3K9me3 in PCH with increasing demethylation activity (Fig 8C). Third, we evaluated the dependence of H3K9me3 in PCH on the concentration of origin sites (Fig 8D). We found an approximately linear response of the H3K9me3 levels up to the wild-type “o” site concentration range of approximately 30 μM.
From simulations of the kinetics of methyl mark propagation in virtual H3K9me3 induction experiments, we conclude that all transient perturbations on the minute time scale will not affect the overall PCH H3K9me3 levels due to the slow response of the system (Fig 8E). The simulations were started from the completely unmodified PCH state (e.g. all nucleosomes in state “n” and “o” sites at every 8th nucleosome), and the H3K9me3 level was followed over time. The steady-state PCH level of 38% was reached after approximately 33 h, corresponding to a propagation rate of 0.35 nucleosomes per hour from a given nucleation site. Notably, these kinetics are comparable to the value of 0.18 nucleosomes per hour measured experimentally for H3K9me3 propagation at the POU5F1 promoter in mouse fibroblasts when inducing H3K9 trimethylation by tethering HP1α (Hathaway et al, 2012). One key parameter to modulate H3K9me3 levels in PCH is the SUV39H concentration (Fig 8F), which might vary between cell types. A 2-fold increase or decrease of the wild-type SUV39H concentration as observed between ESCs and MEFs would raise or lower H3K9me3 levels in PCH from an average value of 38% to about 51% or 28%, respectively.
In summary, we found that the predictions made by our model were in very good agreement with experiments. We conclude that it introduces an appropriate representation of the available data reported here and elsewhere that are relevant for the epigenetic network centered on H3K9me3 in mouse fibroblasts. The model quantitatively describes the properties of euchromatin and PCH determined here under different conditions and explains how a cell can robustly maintain the PCH state without the requirement to invoke additional components such as boundary proteins that bind to chromatin and block linear PCH spreading.
Discussion
Here, we present a comprehensive analysis of the epigenetic network that silences the transcription of major satellite repeats in mouse fibroblasts. Based on data from advanced fluorescence microscopy methods and ChIP-seq, we explain how chromatin and protein interactions of MECP2, MBD1, DNMT1, SUV39H1, SUV39H2, JMJD2B/C, HP1α, HP1β, HP1γ, SUV4-20H1, and SUV4-20H2 are linked to 5meC, H3K9me3, and H4K20me3 modifications in PCH. From our quantitative analysis, we derive a predictive mathematical model that provides insight on how the silenced PCH state in fibroblasts is stably maintained and how it could be transmitted through the cell cycle. As mentioned above, H3K9me3 levels and transcriptional silencing in PCH vary between cell types (Supplementary Fig S2). The underlying mechanisms are only partly understood and beyond the scope of the present study. Nevertheless, our modeling framework provides an approach to evaluate the effect of key parameters. For example, differential regulation could rely on changing the composition of the nucleation complex (Fig 8B) or SUV39H abundance (Fig 8F). In addition, it is noted that SUV39H activity itself is controlled by posttranslational modifications like acetylation (Vaquero et al, 2007), methylation (Wang et al, 2013), or phosphorylation (Park et al, 2014), which links it to additional cellular pathways.
Stably bound PCH complexes of SUV39H require the simultaneous presence of DNA methylation, MECP2, H3K9me3, and HP1
To rationalize our results, we propose that a network of interactions between 5meC, MECP2, MBD1, SUV39H, H3K9me3, and HP1 is responsible for the stably PCH-bound SUV39H complexes that are immobile on the time scale of minutes (Fig 4E, Table 1). Additional factors might further stabilize SUV39H as discussed below. Based on our AUC, FCCS, and F2H experiments, we conclude that most HP1 is present as a homo- or heterodimer in the cell and interacts with SUV39H1 that is in a monomer–dimer equilibrium (Fig 2, Supplementary Fig S5). This interaction is needed for stable SUV39H binding and H3K9 trimethylation in PCH as demonstrated in the triple knockdown of all HP1 isoforms (Fig 3A and B). The link between immobilized HP1 and SUV39H as well as the H3K9 trimethylation mark was further corroborated by FRAP measurements of HP1 in Suv39h dn cells, where H3K9me3 reduction and the loss of the binding partner SUV39H led to a strong increase in HP1 mobility and the loss of immobile HP1 (Supplementary Fig S4C) (Müller et al, 2009).
By quantifying parameters needed for PCH network modeling, our study provides an important extension of previously published FRAP studies of HP1 (Cheutin et al, 2003; Festenstein et al, 2003; Schmiedeberg et al, 2004; Dialynas et al, 2007). The concentration of immobilized HP1α/β/γ (1–3 μM, depending on cell cycle phase) and immobile SUV39H (∼1.4 μM) in PCH measured here is compatible with an HP1 dimer interacting with a SUV39H dimer. The presence of PCH-bound SUV39H-HP1 complexes is consistent with our ChIP-seq analysis of SUV39H1, SUV39H2, HP1β, and H3K9me3, which were enriched at silenced but not at active intergenic/intronic major satellite repeats (Fig 4). These findings are in very good agreement with previous studies: (i) A SUV39H1 mutant lacking its N-terminal chromodomain (SUV39H1-ΔN89) and thus being unable to interact with HP1 showed a homogeneous distribution throughout the nucleus and strongly reduced chromatin interactions in mammalian cell lines (Krouwels et al, 2005). (ii) HP1 dimerization was found to be important for maintaining H3K9me3 in yeast (Haldar et al, 2011). (iii) In vitro experiments showed that SUV39H1 interacts with HP1 by binding the molecular surface formed by dimerization of the chromoshadow-domain (Aagaard et al, 1999; Yamamoto & Sonoda, 2003; Nozawa et al, 2010).
Both HP1 and SUV39H1 are able to recognize H3K9me3 (Lachner et al, 2001; Jacobs & Khorasanizadeh, 2002; Jacobs et al, 2004), and the modification may confer some specificity for PCH binding via local H3K9me3 clusters, since each of the two chromodomains in an HP1 dimer may bind to one H3K9me2/3 residue (Thiru et al, 2004). Nevertheless, it is apparent from our quantification that H3K9me3 alone is not sufficient to stably and specifically tether the HP1-SUV39H complex to PCH. While high-affinity SUV39H binding was hardly present in euchromatin and the stably tethered SUV39H pool was enriched approximately 16- to 50-fold in PCH with respect to euchromatin, H3K9me3 levels were only moderately higher in PCH than in euchromatin (∼1.4-fold). Rather, our quantitative chromatin interaction analysis suggests that SUV39H is tethered to PCH via interactions with multiple factors including MECP2, MBD1, and HP1 (Figs 1B, C and 2C, Supplementary Fig S5B). Since MECP2 binding is linked to 5meC (Nan et al, 1996), 5meC contributes to SUV39H immobilization. Further, H3K9me3 and 5meC are interrelated as iMEF Suv39h dn cells showed reduced DNA methylation at major satellite repeats (Lehnertz et al, 2003; Fuks, 2005) although MECP2 and 5meC colocalized with PCH also in the absence of SUV39H (Supplementary Fig S2B). Notably, 5meC enrichment is not sufficient for PCH formation since a subset of intergenic major satellite repeats displays high 5meC levels but was devoid of SUV39H and transcriptionally active (Fig 4C and D). The above conclusions are supported by a number of previous findings: (i) Interactions of SUV39H1 with MECP2 have been demonstrated (Lunyak et al, 2002; Fujita et al, 2003). (ii) Krouwels et al showed that DNA demethylation increases SUV39H1 mobility and reduces the fraction of immobile SUV39H1, whereas HP1 mobility remained unchanged (Krouwels et al, 2005). This is compatible with our model since only 1–2% of total HP1 were present in the immobilized HP1-SUV39H complex. (iii) The loss of a DNMT1 complex reduced pericentric H3K9 methylation levels in human HeLa cells (Xin et al, 2004). (iv) The knockout of MECP2 in neuronal cells resulted in aberrantly low levels of H3K9me3 in PCH but not in euchromatin (Thatcher & LaSalle, 2006).
We conclude that the stability and specificity of the SUV39H-HP1-MECP2/MBD1 complex in PCH involves protein–protein interactions between these factors and some contribution from an increased 5meC level. Nevertheless, it is likely to be enhanced by additional protein factors. Since the PAX3 and PAX9 transcription factors were not stably bound at PCH (Supplementary Fig S1B and S4B), they are unlikely to play a direct role in stabilizing the HP1-SUV39H nucleation complex. Rather, PAX proteins might regulate the abundance of transcripts in PCH that potentially act as a binding platform for downstream factors (Maison et al, 2011). A number of other factors have been linked to PCH. For example, it was shown that the Mi-2/NuRD complex, which contains several interaction partners of SUV39H and HP1, is necessary to maintain the H3K9me3 mark in PCH (Sims & Wade, 2011). The contribution of such additional factors that enhance SUV39H binding in addition to MECP2 and/or MBD1 is implicitly considered in our quantitative model via the use of the experimentally determined enrichment of the SUV39H high-affinity binding sites in PCH that is independent of their exact molecular composition.
Relatively sparse stably bound SUV39H nucleation complexes are sufficient to propagate H3K9me3 via chromatin looping
The stably bound SUV39H-HP1-MECP2/MBD1 complex in PCH was present at a concentration of approximately 1 μM as inferred from the concentrations of its constituting components of 1.4 μM (dimeric HP1 isoforms), 0.7 μM (dimeric SUV39H1 and SUV39H2), 1.4 μM (MECP2), and 0.2 μM (MBD1), while the nucleosome concentration in PCH was approximately 230 μM (Supplementary Table S7). Thus, bound SUV39H is sparsely distributed. We propose that the H3K9me3 modification is propagated via looping of the nucleosome chain to nucleosomes in spatial proximity from these complexes (Figs 6B and 8G). By ectopically tethering SUV39H1 to the nuclear lamina, we demonstrated experimentally that SUV39H immobilization indeed leads to the locally confined enrichment of H3K9me3 (Fig 6). Thus, chromatin-bound SUV39H might interact with substrate nucleosomes on the same chain or from another chromosome in spatial proximity. Our results are fully consistent with the experimental results from the DamID approach developed by van Steensel et al that uses adenine methylation by DNA adenine methyltransferase (Dam) as readout for interaction. Both the extension of adenine methylation from chromatin-tethered Dam (van Steensel & Henikoff, 2000) as well as the extension of this DNA methylation from Dam tethered to the nuclear lamina (Kind et al, 2013) are in excellent agreement with our mechanism for setting H3K9me3 from SUV39H-bound sites on chromatin or the nuclear lamina.
We would like to emphasize that the propagation of H3K9me3 via the assembly of additional SUV39H-HP1-MECP2/MBD1 nucleation complexes is inherently limited in 3D without the requirement for additional insulator proteins: (i) Only sites that also have pre-existing DNA methylation and bound MECP2/MBD1 in addition to H3K9me3 could lead to nucleation complex assembly. A newly formed H3K9me3 site alone would not be sufficient. (ii) The formation of productive nucleation sites is limited by the available amount of SUV39H. (iii) The H3K9 trimethylation activity originating from the nucleation complexes occurs only within the looping distance of chromatin around these complexes. Typical spreading distances for H3K9me3 limited by the diffusive motion of the chromatin fiber are 5–10 kb, in agreement with other experimental studies discussed elsewhere (Erdel et al, 2013). (iv) There is no preferred direction for diffusive motion of chromatin-bound SUV39H molecules and collisions rather occur in three dimensions with all nucleosomes in spatial proximity that could also be located on a different chromosome. This provides a straightforward explanation for the spherical shape of chromocenters, which may contain pericentromeric repeats from more than one chromosome (Probst & Almouzni, 2008).
SUV39H bookmarks PCH during all cell cycle stages
According to our model, the reestablishment of H3K9me3 in PCH at newly assembled and unmodified histones after replication is mediated by SUV39H that remains bound throughout the cell cycle (Figs 5 and 8G, Supplementary Fig S1C). This process is likely to involve the SUV39H interaction partners MECP2 and MBD1 that show the same persistent binding enhanced by 5meC. This link between H3K9me3 and 5meC is in line with the previous report that the epigenetic inheritance of H3K9me3 involves DNA methylation (Hathaway et al, 2012). Furthermore, a relatively small fraction of HP1 was still immobilized at PCH during G2 phase in the FRAP experiments, which amounts to a significant concentration of approximately 1 μM due to the high level of total HP1. This is consistent with the detection of HP1α/β/γ in a quantitative proteomics analysis of mitotic chromosomes (Ohta et al, 2010), and the presence of HP1α and HP1γ at (peri-)centromeric chromatin on metaphase spreads (Nozawa et al, 2010; Hahn et al, 2013). In addition, SUV39H and HP1 were detected at nascent chromatin following DNA replication (Alabert et al, 2014). Thus, we conclude that the SUV39H nucleation sites persist during all phases of the cell cycle. The constitutive presence of the SUV39H enzymes at PCH together with the finding that SUV39H1 is sufficient to establish de novo H3K9me3 domains when immobilized at the nuclear lamina (Fig 6) has important mechanistic implications: It strongly suggests that the PCH-associated SUV39H molecules are responsible for locally reestablishing the H3K9me3 modification after its dilution during replication (Fig 8G). Thus, immobilized SUV39H molecules might act as bookmarking factors that stably transmit the PCH state through the cell cycle.
H3K9me3 can robustly be maintained in PCH via the nucleation and looping mechanism
Linking modifications of histone residues to their readout by specific protein domains is an important aspect of current theoretical models that describe how epigenetic networks establish and maintain specific chromatin states based on dynamic nucleosome modifications (Dodd et al, 2007; Angel et al, 2011; Hathaway et al, 2012; Hodges & Crabtree, 2012). These include positive feedback loops where modified histones (directly or indirectly) recruit enzymes that catalyze a similar modification on nearby nucleosomes. One class of these models is characterized by relatively robust bistable chromatin states that can stably co-exist for a certain set of conditions (Dodd et al, 2007; Angel et al, 2011). This originates from the presence of multiple positive feedback loops as well as “long-range” interactions along the nucleosome chain. To limit the spreading of a distinct modification to chromatin outside the domain under consideration, the existence of boundary factors is invoked. If H3K9me3 was able to spread within PCH via such a mechanism, one would have to explain how spreading is confined in 3D for the 28 ± 1 chromocenters per nucleus with an average volume of 2.69 ± 0.04 μm3 or approximately 6 Mbp of DNA (Cantaloube et al, 2012). Accordingly, the cell would have to maintain a rather elaborate spherical boundary structure for the 3D confinement of H3K9me3 to PCH, for which there is no evidence. It is also noted that for H3K27me3, the view that boundary factors like CTCF are required to limit domain spreading along the nucleosome chain has been challenged by two recent studies (Schwartz et al, 2012; Van Bortle et al, 2012). Nevertheless, the “nucleation and looping” mechanism proposed here would be fully compatible with the function of insulators as architectural factors that confine the 3D organization of chromatin by establishing interactions between distant sites that would promote or inhibit long-range contacts between nucleosomes and chromatin-bound epigenetic modifiers (Ong & Corces, 2014). Furthermore, we measured that H3K9me3 was less than 2-fold reduced in euchromatin, which suggests that H3K9me3-dependent feedback loops are rather weak. For strong feedback, it would be difficult to explain why the mark would not spread throughout the rest of the genome via the same mechanism as in PCH. Finally, we did not find evidence for bistable H3K9me3 states when perturbing the balance between H3K9me3 methylation and demethylation (Figs 3A, B and 8A–C). Rather, the H3K9me3 distribution obtained from measurements of single cells in dependence of the HP1 concentration showed a gradual transition from wild-type levels to those measured in Suv39h dn cells (Fig 3B).
Recently, an alternative model derived from experiments in which HP1α was recruited to the POU5F1 promoter to induce heterochromatin formation and gene repression was introduced (Hathaway et al, 2012; Hodges & Crabtree, 2012). The experimentally determined H3K9me3 domain with smoothly decreasing borders was modeled with a 1D-lattice model for a chain of 257 nucleosomes, in which the modification is propagated by nearest-neighbor interactions from the nucleation site along the chain. Here, we detected the endogenous equivalent of these ectopic nucleation sites for high-affinity binding of SUV39H complexes in PCH. However, the constraints on protein–chromatin interactions and protein concentrations imposed from our experiments were not compatible with forming stable H3K9me3 domains via linear nearest-neighbor spreading. Furthermore, it provided insufficient specificity with respect to the presence/absence of the high-affinity nucleation sites found in PCH versus euchromatin. In contrast, our nucleation and looping model schematically depicted in Fig 8G was found to be robust with respect to maintaining the experimentally measured PCH features: (i) It provides an intrinsic limit for the SUV39H-dependent extension of H3K9me3 within the system. (ii) Stochastic number fluctuations of cellular factors have little effect (Fig 7C and D). (iii) Perturbations of SUV39H1 binding (Fig 8A), histone demethylation activity (Fig 8C), or the concentrations of SUV39H high-affinity sites (Fig 8D) change the H3K9me3 level only gradually and in a reversible manner. (iv) Transient perturbations of the system in the range of minutes were insignificant, since the H3K9me3 propagation rate is slow with only 0.35 nucleosomes per hour (Fig 8E).
Furthermore, the response of the quantitative model (Fig 7B) toward perturbations was tested experimentally by HP1 knockdown and overexpression of the histone demethylase JMJD2C. In these experiments, a gradual change of the H3K9me3 level depending on HP1 (Figs 3A and 8A, B) or JMJD2C (Fig 8C) concentration was measured, which was reproduced by the model. Likewise, the steady-state methylation level was not bistable since the looping-mediated propagation rate of H3K9me3 decreases approximately linearly with the SUV39H occupancy at the nucleation site. This is consistent with the gradual reduction of GFP expression from the activated POU5F1 promoter observed in MEFs after triggering HP1 recruitment (Hathaway et al, 2012).
Concluding Remarks
Our findings lead us to propose that in mouse fibroblast cells the PCH state is maintained by a nucleation and looping mechanism, in which the H3K9me3 modifications originate from relatively sparsely distributed nucleation sites of stably bound SUV39H complexes (Fig 4E). The local extension of the H3K9me3 modification occurs via looping of the nucleosome chain to mediate methylation of nucleosomes by a chromatin-bound HP1-SUV39H complex in spatial proximity against an unspecific demethylation activity provided by JMJD2 enzymes (Fig 8G). This mechanism is site-specific and robust toward number fluctuations of its components. SUV39H–chromatin complexes persisted through the cell cycle and could act as bookmarking factors for memorizing PCH silencing of transcription (Fig 5). Our model lacks bistable states and it does neither involve nearest-neighbor feedback loops for linear spreading of H3K9me3 nor the presence of locus-specific boundary factors to limit such a process. The predicted behavior of the system according to the nucleation and looping model in response to perturbations was in excellent agreement with the experimental findings. Additionally, it is well suited to rationalize general features of cellular systems that establish, maintain, or modulate epigenetic patterns of characteristic domain size (Erdel et al, 2013). The proposed mechanism is fully consistent with results of studies on the distribution of H3K9 methylation along the nucleosome chain upon chromatin-tethering of HP1 (Hathaway et al, 2012) or the yeast homologue of SUV39H (Kagansky et al, 2009), as well as with the shape of the H3K27me3 domain observed in Arabidopsis that is involved in silencing the floral repressor FLC (Angel et al, 2011). Thus, its conceptual features might be relevant for heritable functional chromatin states at other genomic loci.
Materials and Methods
Cell lines
Experiments were conducted with GFP and RFP constructs in the murine NIH-3T3 fibroblast cell line or in immortalized mouse embryonic fibroblasts (iMEF) wild-type and mutant cell lines (Peters et al, 2001; Schotta et al, 2008; Müller et al, 2009). Autofluorescent proteins were either expressed as stable (inducible) cell lines or introduced via transient transfection as described in the Supplementary Materials and Methods.
Fluorescence microscopy imaging, FRAP, and FCS
Confocal imaging, FRAP and FCS experiments, and associated data analysis were conducted with a Leica TCS SP5 or Zeiss LSM 710 confocal laser scanning microscope as described previously (Müller et al, 2009; Erdel et al, 2010) and in the Supplementary Materials and Methods. Immunofluorescence was conducted with primary anti-H3K9me3 (Millipore, Abcam ab8898), anti-HP1α (Euromedex, 2HP-1H5-AS), anti-HP1β (Euromedex, 1MOD-1A9-AS), anti-HP1γ (Euromedex, 2MOD-1G6-AS) or anti-H4K20me3 (Abcam, ab9053) antibodies and a secondary goat anti-rabbit/mouse Alexa 568 antibody or anti-rabbit/mouse Alexa 633 antibody (Invitrogen, Molecular Probes).
Protein enrichments and H3K9 trimethylation levels were measured from high-resolution microscopy images using the ImageJ software as described in the Supplementary Materials and Methods. FRAP measurements were fitted either to a diffusion model, a binding model or a reaction-diffusion model that incorporates both diffusion and binding processes. The data from the model that yielded the best fit was used for further analysis and modeling (Müller et al, 2009).
Protein interaction analysis by FCCS, F2H, ChIP-seq and AUC
Protein–protein interaction analysis of the soluble nuclear fraction in living cells was done by FCCS (Erdel et al, 2010), and interactions of chromatin-bound proteins were measured via a fluorescent two-hybrid assay (F2H) in the cell nucleus as reported before (Chung et al, 2011). ChIP-seq experiments were conducted as described previously (Teif et al, 2012); the data produced have been deposited to the GEO database (accession number GSE58555). Measurements of HP1 association states with recombinant proteins were performed by analytical ultracentrifugation according to the workflow given in our previous work (Kepert et al, 2003; Fejes Tóth et al, 2005). Details on all methods and associated data analysis are given in the Supplementary Materials and Methods section.
Network modeling
The model of the epigenetic network was calculated for a chromatin fiber of 300 nucleosomes. Each nucleosome on the fiber was able to collide with others via chromatin looping following the collision probability determined by the local concentration of one nucleosome in the proximity of the others as described previously (Rippe et al, 1995; Rippe, 2001; Erdel et al, 2013). The resulting values for an increased local concentration of nucleosomes in the proximity of the first nucleosome at the 0-position due to chromatin looping is shown in Fig 7A with the concentration of high-affinity binding sites (“origins”) measured as described in the text. The model consists of a system of ordinary differential equations (ODEs). The core variables constituting the network (Fig 7B) are the local probability of methylation and the local probabilities of occupation by HP1, SUV39H, and HP1-SUV39H complex that depend on time and the position of nucleosomes and nucleation origins on DNA. The model variables, parameters, and reference values are summarized in Supplementary Table S7. For the euchromatin fiber system, the ODEs lack the nucleation origins. Stochastic kinetic traces and stochastic steady-state distributions were simulated with the Gillespie stochastic simulation algorithm (Gillespie, 2007) implemented in C++. The state of each nucleosome was derived numerically based on the deterministic formalism implemented in Mathematica 9.0 (Wolfram Research). See Supplementary Materials and Methods for details on model implementation and fitting.
Acknowledgments
We are grateful to Malte Wachsmuth, Vladimir Teif, Barna Fodor, and Nick Kepper for help and discussions and thank Thomas Jenuwein, Adrian Bird, Natasha Murzina, and Ken Yamamoto for plasmid vectors and cell lines. The fluorescence microscopy work was conducted in the DKFZ Microscopy Core Facility, the Nikon Imaging Center at the University of Heidelberg, and the EMBL Advanced Light Microscopy Facility. The project was supported by the BMBF projects EpiSys (0315502) and CancerEpiSys (0316049). Additional funding of work in the lab of GS was via a DFG grant within SFB1064.
Author contributions
KMO, FE, TH, and KR designed the study. KMO, JPM, AR, MH, CB, QZ, and SK acquired the experimental data. KMO, JPM, AR, MH, AM, QZ, SK, GS, TH, and KR analyzed and interpreted the data. AM, TH, FE, and KR conducted calculations and mathematical modeling. Manuscript writing was done by KMO, FE, AR, AM, TH, and KR with contributions from all authors regarding critical revisions.
Conflict of interest
The authors declare that they have no conflict of interest.
Supporting Information
Supplementary information for this article is available online: http://msb.embopress.org
References
- Aagaard L, Laible G, Selenko P, Schmid M, Dorn R, Schotta G, Kuhfittig S, Wolf A, Lebersorger A, Singh PB, Reuter G, Jenuwein T. Functional mammalian homologues of the Drosophila PEV-modifier Su(var)3-9 encode centromere-associated proteins which complex with the heterochromatin component M31. EMBO J. 1999;18:1923–1938. doi: 10.1093/emboj/18.7.1923. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Agarwal N, Hardt T, Brero A, Nowak D, Rothbauer U, Becker A, Leonhardt H, Cardoso MC. MeCP2 interacts with HP1 and modulates its heterochromatin association during myogenic differentiation. Nucleic Acids Res. 2007;35:5402–5408. doi: 10.1093/nar/gkm599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Alabert C, Bukowski-Wills JC, Lee SB, Kustatscher G, Nakamura K, de Lima Alves F, Menard P, Mejlvang J, Rappsilber J, Groth A. Nascent chromatin capture proteomics determines chromatin dynamics during DNA replication and identifies unknown fork components. Nat Cell Biol. 2014;16:281–293. doi: 10.1038/ncb2918. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Angel A, Song J, Dean C, Howard M. A polycomb-based switch underlying quantitative epigenetic memory. Nature. 2011;476:105–108. doi: 10.1038/nature10241. [DOI] [PubMed] [Google Scholar]
- Arand J, Spieler D, Karius T, Branco MR, Meilinger D, Meissner A, Jenuwein T, Xu G, Leonhardt H, Wolf V, Walter J. In vivo control of CpG and non-CpG DNA methylation by DNA methyltransferases. PLoS Genet. 2012;8:e1002750. doi: 10.1371/journal.pgen.1002750. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bachman KE, Rountree MR, Baylin SB. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J Biol Chem. 2001;276:32282–32287. doi: 10.1074/jbc.M104661200. [DOI] [PubMed] [Google Scholar]
- Ball LJ, Murzina NV, Broadhurst RW, Raine AR, Archer SJ, Stott FJ, Murzin AG, Singh PB, Domaille PJ, Laue ED. Structure of the chromatin binding (chromo) domain from mouse modifier protein 1. EMBO J. 1997;16:2473–2481. doi: 10.1093/emboj/16.9.2473. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A. An operational definition of epigenetics. Genes Dev. 2009;23:781–783. doi: 10.1101/gad.1787609. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brero A, Easwaran HP, Nowak D, Grunewald I, Cremer T, Leonhardt H, Cardoso MC. Methyl CpG-binding proteins induce large-scale chromatin reorganization during terminal differentiation. J Cell Biol. 2005;169:733–743. doi: 10.1083/jcb.200502062. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bulut-Karslioglu A, Perrera V, Scaranaro M, de la Rosa-Velazquez IA, van de Nobelen S, Shukeir N, Popow J, Gerle B, Opravil S, Pagani M, Meidhof S, Brabletz T, Manke T, Lachner M, Jenuwein T. A transcription factor-based mechanism for mouse heterochromatin formation. Nat Struct Mol Biol. 2012;19:1023–1030. doi: 10.1038/nsmb.2382. [DOI] [PubMed] [Google Scholar]
- Byrum SD, Taverna SD, Tackett AJ. Purification of a specific native genomic locus for proteomic analysis. Nucleic Acids Res. 2013;41:e195. doi: 10.1093/nar/gkt822. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Campos EI, Reinberg D. Histones: annotating chromatin. Annu Rev Genet. 2009;43:559–599. doi: 10.1146/annurev.genet.032608.103928. [DOI] [PubMed] [Google Scholar]
- Cantaloube S, Romeo K, Le Baccon P, Almouzni G, Quivy JP. Characterization of chromatin domains by 3D fluorescence microscopy: an automated methodology for quantitative analysis and nuclei screening. BioEssays. 2012;34:509–517. doi: 10.1002/bies.201100188. [DOI] [PubMed] [Google Scholar]
- Cheutin T, McNairn AJ, Jenuwein T, Gilbert DM, Singh PB, Misteli T. Maintenance of stable heterochromatin domains by dynamic HP1 binding. Science. 2003;299:721–725. doi: 10.1126/science.1078572. [DOI] [PubMed] [Google Scholar]
- Chin HG, Esteve PO, Pradhan M, Benner J, Patnaik D, Carey MF, Pradhan S. Automethylation of G9a and its implication in wider substrate specificity and HP1 binding. Nucleic Acids Res. 2007;35:7313–7323. doi: 10.1093/nar/gkm726. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chung I, Leonhardt H, Rippe K. De novo assembly of a PML nuclear subcompartment occurs through multiple pathways and induces telomere elongation. J Cell Sci. 2011;124:3603–3618. doi: 10.1242/jcs.084681. [DOI] [PubMed] [Google Scholar]
- Clapier CR, Cairns BR. The biology of chromatin remodeling complexes. Annu Rev Biochem. 2009;78:273–304. doi: 10.1146/annurev.biochem.77.062706.153223. [DOI] [PubMed] [Google Scholar]
- Craig JM, Earle E, Canham P, Wong LH, Anderson M, Choo KH. Analysis of mammalian proteins involved in chromatin modification reveals new metaphase centromeric proteins and distinct chromosomal distribution patterns. Hum Mol Genet. 2003;12:3109–3121. doi: 10.1093/hmg/ddg330. [DOI] [PubMed] [Google Scholar]
- Dialynas GK, Terjung S, Brown JP, Aucott RL, Baron-Luhr B, Singh PB, Georgatos SD. Plasticity of HP1 proteins in mammalian cells. J Cell Sci. 2007;120:3415–3424. doi: 10.1242/jcs.012914. [DOI] [PubMed] [Google Scholar]
- Dodd IB, Micheelsen MA, Sneppen K, Thon G. Theoretical analysis of epigenetic cell memory by nucleosome modification. Cell. 2007;129:813–822. doi: 10.1016/j.cell.2007.02.053. [DOI] [PubMed] [Google Scholar]
- Easwaran HP, Schermelleh L, Leonhardt H, Cardoso MC. Replication-independent chromatin loading of Dnmt1 during G2 and M phases. EMBO Rep. 2004;5:1181–1186. doi: 10.1038/sj.embor.7400295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Efroni S, Duttagupta R, Cheng J, Dehghani H, Hoeppner DJ, Dash C, Bazett-Jones DP, Le Grice S, McKay RD, Buetow KH, Gingeras TR, Misteli T, Meshorer E. Global transcription in pluripotent embryonic stem cells. Cell Stem Cell. 2008;2:437–447. doi: 10.1016/j.stem.2008.03.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eissenberg JC, Reuter G. Cellular mechanism for targeting heterochromatin formation in Drosophila. Int Rev Cell Mol Biol. 2009;273:1–47. doi: 10.1016/S1937-6448(08)01801-7. [DOI] [PubMed] [Google Scholar]
- Erdel F, Schubert T, Marth C, Langst G, Rippe K. Human ISWI chromatin-remodeling complexes sample nucleosomes via transient binding reactions and become immobilized at active sites. Proc Natl Acad Sci USA. 2010;107:19873–19878. doi: 10.1073/pnas.1003438107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Erdel F, Krug J, Längst G, Rippe K. Targeting chromatin remodelers: signals and search mechanisms. Biochim Biophys Acta. 2011a;1809:497–508. doi: 10.1016/j.bbagrm.2011.06.005. [DOI] [PubMed] [Google Scholar]
- Erdel F, Müller-Ott K, Baum M, Wachsmuth M, Rippe K. Dissecting chromatin interactions in living cells from protein mobility maps. Chromosome Res. 2011b;19:99–115. doi: 10.1007/s10577-010-9155-6. [DOI] [PubMed] [Google Scholar]
- Erdel F, Müller-Ott K, Rippe K. Establishing epigenetic domains via chromatin-bound histone modifiers. Ann N Y Acad Sci. 2013;1305:29–43. doi: 10.1111/nyas.12262. [DOI] [PubMed] [Google Scholar]
- Esteve PO, Chin HG, Smallwood A, Feehery GR, Gangisetty O, Karpf AR, Carey MF, Pradhan S. Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication. Genes Dev. 2006;20:3089–3103. doi: 10.1101/gad.1463706. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fejes Tóth K, Mazurkiewicz J, Rippe K. Association states of the nucleosome assembly protein 1 and its complexes with histones. J Biol Chem. 2005;280:15690–15699. doi: 10.1074/jbc.M413329200. [DOI] [PubMed] [Google Scholar]
- Festenstein R, Pagakis SN, Hiragami K, Lyon D, Verreault A, Sekkali B, Kioussis D. Modulation of heterochromatin protein 1 dynamics in primary Mammalian cells. Science. 2003;299:719–721. doi: 10.1126/science.1078694. [DOI] [PubMed] [Google Scholar]
- Fischle W, Wang Y, Jacobs SA, Kim Y, Allis CD, Khorasanizadeh S. Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by polycomb and HP1 chromodomains. Genes Dev. 2003;17:1870–1881. doi: 10.1101/gad.1110503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fischle W, Tseng BS, Dormann HL, Ueberheide BM, Garcia BA, Shabanowitz J, Hunt DF, Funabiki H, Allis CD. Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation. Nature. 2005;438:1116–1122. doi: 10.1038/nature04219. [DOI] [PubMed] [Google Scholar]
- Fodor BD, Kubicek S, Yonezawa M, O'Sullivan RJ, Sengupta R, Perez-Burgos L, Opravil S, Mechtler K, Schotta G, Jenuwein T. Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells. Genes Dev. 2006;20:1557–1562. doi: 10.1101/gad.388206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fodor BD, Shukeir N, Reuter G, Jenuwein T. Mammalian Su(var) genes in chromatin control. Annu Rev Cell Dev Biol. 2010;26:471–501. doi: 10.1146/annurev.cellbio.042308.113225. [DOI] [PubMed] [Google Scholar]
- Fujita N, Takebayashi S, Okumura K, Kudo S, Chiba T, Saya H, Nakao M. Methylation-mediated transcriptional silencing in euchromatin by methyl-CpG binding protein MBD1 isoforms. Mol Cell Biol. 1999;19:6415–6426. doi: 10.1128/mcb.19.9.6415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fujita N, Watanabe S, Ichimura T, Tsuruzoe S, Shinkai Y, Tachibana M, Chiba T, Nakao M. Methyl-CpG binding domain 1 (MBD1) interacts with the Suv39h1-HP1 heterochromatic complex for DNA methylation-based transcriptional repression. J Biol Chem. 2003;278:24132–24138. doi: 10.1074/jbc.M302283200. [DOI] [PubMed] [Google Scholar]
- Fuks F, Hurd PJ, Deplus R, Kouzarides T. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res. 2003;31:2305–2312. doi: 10.1093/nar/gkg332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fuks F. DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev. 2005;15:490–495. doi: 10.1016/j.gde.2005.08.002. [DOI] [PubMed] [Google Scholar]
- Gillespie DT. Stochastic simulation of chemical kinetics. Annu Rev Phys Chem. 2007;58:35–55. doi: 10.1146/annurev.physchem.58.032806.104637. [DOI] [PubMed] [Google Scholar]
- Grewal SI, Jia S. Heterochromatin revisited. Nat Rev Genet. 2007;8:35–46. doi: 10.1038/nrg2008. [DOI] [PubMed] [Google Scholar]
- Hahn M, Dambacher S, Dulev S, Kuznetsova AY, Eck S, Worz S, Sadic D, Schulte M, Mallm JP, Maiser A, Debs P, von Melchner H, Leonhardt H, Schermelleh L, Rohr K, Rippe K, Storchova Z, Schotta G. Suv4-20h2 mediates chromatin compaction and is important for cohesin recruitment to heterochromatin. Genes Dev. 2013;27:859–872. doi: 10.1101/gad.210377.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Haldar S, Saini A, Nanda JS, Saini S, Singh J. Role of Swi6/HP1 self-association-mediated recruitment of Clr4/Suv39 in establishment and maintenance of heterochromatin in fission yeast. J Biol Chem. 2011;286:9308–9320. doi: 10.1074/jbc.M110.143198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hathaway NA, Bell O, Hodges C, Miller EL, Neel DS, Crabtree GR. Dynamics and memory of heterochromatin in living cells. Cell. 2012;149:1447–1460. doi: 10.1016/j.cell.2012.03.052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hayakawa T, Haraguchi T, Masumoto H, Hiraoka Y. Cell cycle behavior of human HP1 subtypes: distinct molecular domains of HP1 are required for their centromeric localization during interphase and metaphase. J Cell Sci. 2003;116:3327–3338. doi: 10.1242/jcs.00635. [DOI] [PubMed] [Google Scholar]
- Hiragami K, Festenstein R. Heterochromatin protein 1: a pervasive controlling influence. Cell Mol Life Sci. 2005;62:2711–2726. doi: 10.1007/s00018-005-5287-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hirota T, Lipp JJ, Toh BH, Peters JM. Histone H3 serine 10 phosphorylation by Aurora B causes HP1 dissociation from heterochromatin. Nature. 2005;438:1176–1180. doi: 10.1038/nature04254. [DOI] [PubMed] [Google Scholar]
- Hodges C, Crabtree GR. Dynamics of inherently bounded histone modification domains. Proc Natl Acad Sci USA. 2012;109:13296–13301. doi: 10.1073/pnas.1211172109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jacobs SA, Khorasanizadeh S. Structure of HP1 chromodomain bound to a lysine 9-methylated histone H3 tail. Science. 2002;295:2080–2083. doi: 10.1126/science.1069473. [DOI] [PubMed] [Google Scholar]
- Jacobs SA, Fischle W, Khorasanizadeh S. Assays for the determination of structure and dynamics of the interaction of the chromodomain with histone peptides. Meth Enzymol. 2004;376:131–148. doi: 10.1016/S0076-6879(03)76009-1. [DOI] [PubMed] [Google Scholar]
- Kagansky A, Folco HD, Almeida R, Pidoux AL, Boukaba A, Simmer F, Urano T, Hamilton GL, Allshire RC. Synthetic heterochromatin bypasses RNAi and centromeric repeats to establish functional centromeres. Science. 2009;324:1716–1719. doi: 10.1126/science.1172026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kepert JF, Fejes Tóth K, Caudron M, Mücke N, Langowski J, Rippe K. Conformation of reconstituted mononucleosomes and effect of linker histone H1 binding studied by scanning force microscopy. Biophys J. 2003;85:4012–4022. doi: 10.1016/S0006-3495(03)74815-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kind J, Pagie L, Ortabozkoyun H, Boyle S, de Vries SS, Janssen H, Amendola M, Nolen LD, Bickmore WA, van Steensel B. Single-cell dynamics of genome-nuclear lamina interactions. Cell. 2013;153:178–192. doi: 10.1016/j.cell.2013.02.028. [DOI] [PubMed] [Google Scholar]
- Kourmouli N, Jeppesen P, Mahadevhaiah S, Burgoyne P, Wu R, Gilbert DM, Bongiorni S, Prantera G, Fanti L, Pimpinelli S, Shi W, Fundele R, Singh PB. Heterochromatin and tri-methylated lysine 20 of histone H4 in animals. J Cell Sci. 2004;117:2491–2501. doi: 10.1242/jcs.01238. [DOI] [PubMed] [Google Scholar]
- Krouwels IM, Wiesmeijer K, Abraham TE, Molenaar C, Verwoerd NP, Tanke HJ, Dirks RW. A glue for heterochromatin maintenance: stable SUV39H1 binding to heterochromatin is reinforced by the SET domain. J Cell Biol. 2005;170:537–549. doi: 10.1083/jcb.200502154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kwon SH, Workman JL. The heterochromatin protein 1 (HP1) family: put away a bias toward HP1. Mol Cells. 2008;26:217–227. [PubMed] [Google Scholar]
- Lachner M, O'Carroll D, Rea S, Mechtler K, Jenuwein T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature. 2001;410:116–120. doi: 10.1038/35065132. [DOI] [PubMed] [Google Scholar]
- Lehnertz B, Ueda Y, Derijck AA, Braunschweig U, Perez-Burgos L, Kubicek S, Chen T, Li E, Jenuwein T, Peters AH. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol. 2003;13:1192–1200. doi: 10.1016/s0960-9822(03)00432-9. [DOI] [PubMed] [Google Scholar]
- Lewis JD, Meehan RR, Henzel WJ, Maurer-Fogy I, Jeppesen P, Klein F, Bird A. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell. 1992;69:905–914. doi: 10.1016/0092-8674(92)90610-o. [DOI] [PubMed] [Google Scholar]
- Lorthongpanich C, Cheow LF, Balu S, Quake SR, Knowles BB, Burkholder WF, Solter D, Messerschmidt DM. Single-cell DNA-methylation analysis reveals epigenetic chimerism in preimplantation embryos. Science. 2013;341:1110–1112. doi: 10.1126/science.1240617. [DOI] [PubMed] [Google Scholar]
- Loyola A, Tagami H, Bonaldi T, Roche D, Quivy JP, Imhof A, Nakatani Y, Dent SY, Almouzni G. The HP1alpha-CAF1-SetDB1-containing complex provides H3K9me1 for Suv39-mediated K9me3 in pericentric heterochromatin. EMBO Rep. 2009;10:769–775. doi: 10.1038/embor.2009.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lunyak VV, Burgess R, Prefontaine GG, Nelson C, Sze SH, Chenoweth J, Schwartz P, Pevzner PA, Glass C, Mandel G, Rosenfeld MG. Corepressor-dependent silencing of chromosomal regions encoding neuronal genes. Science. 2002;298:1747–1752. doi: 10.1126/science.1076469. [DOI] [PubMed] [Google Scholar]
- Maison C, Almouzni G. HP1 and the dynamics of heterochromatin maintenance. Nat Rev Mol Cell Biol. 2004;5:296–304. doi: 10.1038/nrm1355. [DOI] [PubMed] [Google Scholar]
- Maison C, Bailly D, Roche D, de Oca RM, Probst AV, Vassias I, Dingli F, Lombard B, Loew D, Quivy JP, Almouzni G. SUMOylation promotes de novo targeting of HP1alpha to pericentric heterochromatin. Nat Genet. 2011;43:220–227. doi: 10.1038/ng.765. [DOI] [PubMed] [Google Scholar]
- Martens JH, O'Sullivan RJ, Braunschweig U, Opravil S, Radolf M, Steinlein P, Jenuwein T. The profile of repeat-associated histone lysine methylation states in the mouse epigenome. EMBO J. 2005;24:800–812. doi: 10.1038/sj.emboj.7600545. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mateescu B, England P, Halgand F, Yaniv M, Muchardt C. Tethering of HP1 proteins to chromatin is relieved by phosphoacetylation of histone H3. EMBO Rep. 2004;5:490–496. doi: 10.1038/sj.embor.7400139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McBryant SJ, Adams VH, Hansen JC. Chromatin architectural proteins. Chromosome Res. 2006;14:39–51. doi: 10.1007/s10577-006-1025-x. [DOI] [PubMed] [Google Scholar]
- McManus KJ, Biron VL, Heit R, Underhill DA, Hendzel MJ. Dynamic changes in histone H3 lysine 9 methylations: identification of a mitosis-specific function for dynamic methylation in chromosome congression and segregation. J Biol Chem. 2006;281:8888–8897. doi: 10.1074/jbc.M505323200. [DOI] [PubMed] [Google Scholar]
- Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, Zhang X, Bernstein BE, Nusbaum C, Jaffe DB, Gnirke A, Jaenisch R, Lander ES. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature. 2008;454:766–770. doi: 10.1038/nature07107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Melcher M, Schmid M, Aagaard L, Selenko P, Laible G, Jenuwein T. Structure-function analysis of SUV39H1 reveals a dominant role in heterochromatin organization, chromosome segregation, and mitotic progression. Mol Cell Biol. 2000;20:3728–3741. doi: 10.1128/mcb.20.10.3728-3741.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meshorer E, Misteli T. Chromatin in pluripotent embryonic stem cells and differentiation. Nat Rev Mol Cell Biol. 2006;7:540–546. doi: 10.1038/nrm1938. [DOI] [PubMed] [Google Scholar]
- Müller KP, Erdel F, Caudron-Herger M, Marth C, Fodor BD, Richter M, Scaranaro M, Beaudouin J, Wachsmuth M, Rippe K. Multiscale analysis of dynamics and interactions of heterochromatin protein 1 by fluorescence fluctuation microscopy. Biophys J. 2009;97:2876–2885. doi: 10.1016/j.bpj.2009.08.057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nan X, Tate P, Li E, Bird A. DNA methylation specifies chromosomal localization of MeCP2. Mol Cell Biol. 1996;16:414–421. doi: 10.1128/mcb.16.1.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nielsen AL, Oulad-Abdelghani M, Ortiz JA, Remboutsika E, Chambon P, Losson R. Heterochromatin formation in mammalian cells: interaction between histones and HP1 proteins. Mol Cell. 2001;7:729–739. doi: 10.1016/s1097-2765(01)00218-0. [DOI] [PubMed] [Google Scholar]
- Nozawa RS, Nagao K, Masuda HT, Iwasaki O, Hirota T, Nozaki N, Kimura H, Obuse C. Human POGZ modulates dissociation of HP1alpha from mitotic chromosome arms through Aurora B activation. Nat Cell Biol. 2010;12:719–727. doi: 10.1038/ncb2075. [DOI] [PubMed] [Google Scholar]
- Ohta S, Bukowski-Wills JC, Sanchez-Pulido L, Alves Fde L, Wood L, Chen ZA, Platani M, Fischer L, Hudson DF, Ponting CP, Fukagawa T, Earnshaw WC, Rappsilber J. The protein composition of mitotic chromosomes determined using multiclassifier combinatorial proteomics. Cell. 2010;142:810–821. doi: 10.1016/j.cell.2010.07.047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ong CT, Corces VG. CTCF: an architectural protein bridging genome topology and function. Nat Rev Genet. 2014;15:234–246. doi: 10.1038/nrg3663. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Park SH, Yu SE, Chai YG, Jang YK. CDK2-dependent phosphorylation of Suv39H1 is involved in control of heterochromatin replication during cell cycle progression. Nucleic Acids Res. 2014;42:6196–6207. doi: 10.1093/nar/gku263. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Peters AH, O'Carroll D, Scherthan H, Mechtler K, Sauer S, Schofer C, Weipoltshammer K, Pagani M, Lachner M, Kohlmaier A, Opravil S, Doyle M, Sibilia M, Jenuwein T. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell. 2001;107:323–337. doi: 10.1016/s0092-8674(01)00542-6. [DOI] [PubMed] [Google Scholar]
- Probst AV, Almouzni G. Pericentric heterochromatin: dynamic organization during early development in mammals. Differentiation. 2008;76:15–23. doi: 10.1111/j.1432-0436.2007.00220.x. [DOI] [PubMed] [Google Scholar]
- Ringrose L, Chabanis S, Angrand PO, Woodroofe C, Stewart AF. Quantitative comparison of DNA looping in vitro and in vivo: chromatin increases effective DNA flexibility at short distances. EMBO J. 1999;18:6630–6641. doi: 10.1093/emboj/18.23.6630. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rippe K, von Hippel PH, Langowski J. Action at a distance: DNA-looping and initiation of transcription. Trends Biochem Sci. 1995;20:500–506. doi: 10.1016/s0968-0004(00)89117-3. [DOI] [PubMed] [Google Scholar]
- Rippe K. Making contacts on a nucleic acid polymer. Trends Biochem Sci. 2001;26:733–740. doi: 10.1016/s0968-0004(01)01978-8. [DOI] [PubMed] [Google Scholar]
- Rosnoblet C, Vandamme J, Volkel P, Angrand PO. Analysis of the human HP1 interactome reveals novel binding partners. Biochem Biophys Res Com. 2011;413:206–211. doi: 10.1016/j.bbrc.2011.08.059. [DOI] [PubMed] [Google Scholar]
- Rothbauer U, Zolghadr K, Muyldermans S, Schepers A, Cardoso MC, Leonhardt H. A versatile nanotrap for biochemical and functional studies with fluorescent fusion proteins. Mol Cell Proteomics. 2008;7:282–289. doi: 10.1074/mcp.M700342-MCP200. [DOI] [PubMed] [Google Scholar]
- Schermelleh L, Haemmer A, Spada F, Rosing N, Meilinger D, Rothbauer U, Cardoso MC, Leonhardt H. Dynamics of Dnmt1 interaction with the replication machinery and its role in postreplicative maintenance of DNA methylation. Nucleic Acids Res. 2007;35:4301–4312. doi: 10.1093/nar/gkm432. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schmiedeberg L, Weisshart K, Diekmann S, Meyer Zu Hoerste G, Hemmerich P. High- and low-mobility populations of HP1 in heterochromatin of mammalian cells. Mol Biol Cell. 2004;15:2819–2833. doi: 10.1091/mbc.E03-11-0827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schotta G, Ebert A, Krauss V, Fischer A, Hoffmann J, Rea S, Jenuwein T, Dorn R, Reuter G. Central role of Drosophila SU(VAR)3-9 in histone H3-K9 methylation and heterochromatic gene silencing. EMBO J. 2002;21:1121–1131. doi: 10.1093/emboj/21.5.1121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schotta G, Lachner M, Sarma K, Ebert A, Sengupta R, Reuter G, Reinberg D, Jenuwein T. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev. 2004;18:1251–1262. doi: 10.1101/gad.300704. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schotta G, Sengupta R, Kubicek S, Malin S, Kauer M, Callen E, Celeste A, Pagani M, Opravil S, De La Rosa-Velazquez IA, Espejo A, Bedford M, Nussenzweig A, Busslinger M, Jenuwein T. A chromatin-wide transition to H4K20 mono-methylation impairs genome integrity and programmed DNA rearrangements in the mouse. Genes Dev. 2008;22:2048–2061. doi: 10.1101/gad.476008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schreiber SL, Bernstein BE. Signaling network model of chromatin. Cell. 2002;111:771–778. doi: 10.1016/s0092-8674(02)01196-0. [DOI] [PubMed] [Google Scholar]
- Schwartz YB, Linder-Basso D, Kharchenko PV, Tolstorukov MY, Kim M, Li HB, Gorchakov AA, Minoda A, Shanower G, Alekseyenko AA, Riddle NC, Jung YL, Gu T, Plachetka A, Elgin SC, Kuroda MI, Park PJ, Savitsky M, Karpen GH, Pirrotta V. Nature and function of insulator protein binding sites in the Drosophila genome. Genome Res. 2012;22:2188–2198. doi: 10.1101/gr.138156.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sedighi M, Sengupta AM. Epigenetic chromatin silencing: bistability and front propagation. Phys Biol. 2007;4:246–255. doi: 10.1088/1478-3975/4/4/002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sims JK, Wade PA. Mi-2/NuRD complex function is required for normal S phase progression and assembly of pericentric heterochromatin. Mol Biol Cell. 2011;22:3094–3102. doi: 10.1091/mbc.E11-03-0258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smallwood A, Esteve PO, Pradhan S, Carey M. Functional cooperation between HP1 and DNMT1 mediates gene silencing. Genes Dev. 2007;21:1169–1178. doi: 10.1101/gad.1536807. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sneppen K, Micheelsen MA, Dodd IB. Ultrasensitive gene regulation by positive feedback loops in nucleosome modification. Mol Syst Biol. 2008;4:182. doi: 10.1038/msb.2008.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Souza PP, Volkel P, Trinel D, Vandamme J, Rosnoblet C, Heliot L, Angrand PO. The histone methyltransferase SUV420H2 and heterochromatin proteins HP1 interact but show different dynamic behaviours. BMC Cell Biol. 2009;10:41. doi: 10.1186/1471-2121-10-41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van Steensel B, Henikoff S. Identification of in vivo DNA targets of chromatin proteins using tethered dam methyltransferase. Nat Biotechnol. 2000;18:424–428. doi: 10.1038/74487. [DOI] [PubMed] [Google Scholar]
- Tachibana M, Sugimoto K, Nozaki M, Ueda J, Ohta T, Ohki M, Fukuda M, Takeda N, Niida H, Kato H, Shinkai Y. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 2002;16:1779–1791. doi: 10.1101/gad.989402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taddei A, Maison C, Roche D, Almouzni G. Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases. Nat Cell Biol. 2001;3:114–120. doi: 10.1038/35055010. [DOI] [PubMed] [Google Scholar]
- Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ. How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat Struct Mol Biol. 2007;14:1025–1040. doi: 10.1038/nsmb1338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Teif VB, Vainshtein Y, Caudron-Herger M, Mallm JP, Marth C, Hofer T, Rippe K. Genome-wide nucleosome positioning during embryonic stem cell development. Nat Struct Mol Biol. 2012;19:1185–1191. doi: 10.1038/nsmb.2419. [DOI] [PubMed] [Google Scholar]
- Thatcher KN, LaSalle JM. Dynamic changes in Histone H3 lysine 9 acetylation localization patterns during neuronal maturation require MeCP2. Epigenetics. 2006;1:24–31. doi: 10.4161/epi.1.1.2339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thiru A, Nietlispach D, Mott HR, Okuwaki M, Lyon D, Nielsen PR, Hirshberg M, Verreault A, Murzina NV, Laue ED. Structural basis of HP1/PXVXL motif peptide interactions and HP1 localisation to heterochromatin. EMBO J. 2004;23:489–499. doi: 10.1038/sj.emboj.7600088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Van Bortle K, Ramos E, Takenaka N, Yang J, Wahi JE, Corces VG. Drosophila CTCF tandemly aligns with other insulator proteins at the borders of H3K27me3 domains. Genome Res. 2012;22:2176–2187. doi: 10.1101/gr.136788.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vaquero A, Scher M, Erdjument-Bromage H, Tempst P, Serrano L, Reinberg D. SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation. Nature. 2007;450:440–444. doi: 10.1038/nature06268. [DOI] [PubMed] [Google Scholar]
- Wang D, Zhou J, Liu X, Lu D, Shen C, Du Y, Wei FZ, Song B, Lu X, Yu Y, Wang L, Zhao Y, Wang H, Yang Y, Akiyama Y, Zhang H, Zhu WG. Methylation of SUV39H1 by SET7/9 results in heterochromatin relaxation and genome instability. Proc Natl Acad Sci USA. 2013;110:5516–5521. doi: 10.1073/pnas.1216596110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, An P, Antonarakis SE, Attwood J, Baertsch R, Bailey J, Barlow K, Beck S, Berry E, Birren B, Bloom T, Bork P, et al. Initial sequencing and comparative analysis of the mouse genome. Nature. 2002;420:520–562. doi: 10.1038/nature01262. [DOI] [PubMed] [Google Scholar]
- Wilson VL, Jones PA. Chemical carcinogen-mediated decreases in DNA 5-methylcytosine content of BALB/3T3 cells. Carcinogenesis. 1984;5:1027–1031. doi: 10.1093/carcin/5.8.1027. [DOI] [PubMed] [Google Scholar]
- Xin H, Yoon HG, Singh PB, Wong J, Qin J. Components of a pathway maintaining histone modification and heterochromatin protein 1 binding at the pericentric heterochromatin in Mammalian cells. J Biol Chem. 2004;279:9539–9546. doi: 10.1074/jbc.M311587200. [DOI] [PubMed] [Google Scholar]
- Yamagata K, Yamazaki T, Miki H, Ogonuki N, Inoue K, Ogura A, Baba T. Centromeric DNA hypomethylation as an epigenetic signature discriminates between germ and somatic cell lineages. Dev Biol. 2007;312:419–426. doi: 10.1016/j.ydbio.2007.09.041. [DOI] [PubMed] [Google Scholar]
- Yamamoto K, Sonoda M. Self-interaction of heterochromatin protein 1 is required for direct binding to histone methyltransferase, SUV39H1. Biochem Biophys Res Com. 2003;301:287–292. doi: 10.1016/s0006-291x(02)03021-8. [DOI] [PubMed] [Google Scholar]
- Zee BM, Levin RS, Xu B, LeRoy G, Wingreen NS, Garcia BA. In vivo residue-specific histone methylation dynamics. J Biol Chem. 2010;285:3341–3350. doi: 10.1074/jbc.M109.063784. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zolghadr K, Mortusewicz O, Rothbauer U, Kleinhans R, Goehler H, Wanker EE, Cardoso MC, Leonhardt H. A fluorescent two-hybrid assay for direct visualization of protein interactions in living cells. Mol Cell Proteomics. 2008;7:2279–2287. doi: 10.1074/mcp.M700548-MCP200. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.